Cargando…

Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis

BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detail...

Descripción completa

Detalles Bibliográficos
Autores principales: Garam, Nóra, Prohászka, Zoltán, Szilágyi, Ágnes, Aigner, Christof, Schmidt, Alice, Gaggl, Martina, Sunder-Plassmann, Gere, Bajcsi, Dóra, Brunner, Jürgen, Dumfarth, Alexandra, Cejka, Daniel, Flaschberger, Stefan, Flögelova, Hana, Haris, Ágnes, Hartmann, Ágnes, Heilos, Andreas, Mueller, Thomas, Rusai, Krisztina, Arbeiter, Klaus, Hofer, Johannes, Jakab, Dániel, Sinkó, Mária, Szigeti, Erika, Bereczki, Csaba, Janko, Viktor, Kelen, Kata, Reusz, György S, Szabó, Attila J, Klenk, Nóra, Kóbor, Krisztina, Kojc, Nika, Knechtelsdorfer, Maarten, Laganovic, Mario, Lungu, Adrian Catalin, Meglic, Anamarija, Rus, Rina, Kersnik-Levart, Tanja, Macioniene, Ernesta, Miglinas, Marius, Pawłowska, Anna, Stompór, Tomasz, Podracka, Ludmila, Rudnicki, Michael, Mayer, Gert, Rysava, Romana, Reiterova, Jana, Saraga, Marijan, Seeman, Tomáš, Zieg, Jakub, Sládková, Eva, Szabó, Tamás, Capitanescu, Andrei, Stancu, Simona, Tisljar, Miroslav, Galesic, Kresimir, Tislér, András, Vainumäe, Inga, Windpessl, Martin, Zaoral, Tomas, Zlatanova, Galia, Csuka, Dorottya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147314/
https://www.ncbi.nlm.nih.gov/pubmed/32296528
http://dx.doi.org/10.1093/ckj/sfz073
_version_ 1783520396030509056
author Garam, Nóra
Prohászka, Zoltán
Szilágyi, Ágnes
Aigner, Christof
Schmidt, Alice
Gaggl, Martina
Sunder-Plassmann, Gere
Bajcsi, Dóra
Brunner, Jürgen
Dumfarth, Alexandra
Cejka, Daniel
Flaschberger, Stefan
Flögelova, Hana
Haris, Ágnes
Hartmann, Ágnes
Heilos, Andreas
Mueller, Thomas
Rusai, Krisztina
Arbeiter, Klaus
Hofer, Johannes
Jakab, Dániel
Sinkó, Mária
Szigeti, Erika
Bereczki, Csaba
Janko, Viktor
Kelen, Kata
Reusz, György S
Szabó, Attila J
Klenk, Nóra
Kóbor, Krisztina
Kojc, Nika
Knechtelsdorfer, Maarten
Laganovic, Mario
Lungu, Adrian Catalin
Meglic, Anamarija
Rus, Rina
Kersnik-Levart, Tanja
Macioniene, Ernesta
Miglinas, Marius
Pawłowska, Anna
Stompór, Tomasz
Podracka, Ludmila
Rudnicki, Michael
Mayer, Gert
Rysava, Romana
Reiterova, Jana
Saraga, Marijan
Seeman, Tomáš
Zieg, Jakub
Sládková, Eva
Szabó, Tamás
Capitanescu, Andrei
Stancu, Simona
Tisljar, Miroslav
Galesic, Kresimir
Tislér, András
Vainumäe, Inga
Windpessl, Martin
Zaoral, Tomas
Zlatanova, Galia
Csuka, Dorottya
author_facet Garam, Nóra
Prohászka, Zoltán
Szilágyi, Ágnes
Aigner, Christof
Schmidt, Alice
Gaggl, Martina
Sunder-Plassmann, Gere
Bajcsi, Dóra
Brunner, Jürgen
Dumfarth, Alexandra
Cejka, Daniel
Flaschberger, Stefan
Flögelova, Hana
Haris, Ágnes
Hartmann, Ágnes
Heilos, Andreas
Mueller, Thomas
Rusai, Krisztina
Arbeiter, Klaus
Hofer, Johannes
Jakab, Dániel
Sinkó, Mária
Szigeti, Erika
Bereczki, Csaba
Janko, Viktor
Kelen, Kata
Reusz, György S
Szabó, Attila J
Klenk, Nóra
Kóbor, Krisztina
Kojc, Nika
Knechtelsdorfer, Maarten
Laganovic, Mario
Lungu, Adrian Catalin
Meglic, Anamarija
Rus, Rina
Kersnik-Levart, Tanja
Macioniene, Ernesta
Miglinas, Marius
Pawłowska, Anna
Stompór, Tomasz
Podracka, Ludmila
Rudnicki, Michael
Mayer, Gert
Rysava, Romana
Reiterova, Jana
Saraga, Marijan
Seeman, Tomáš
Zieg, Jakub
Sládková, Eva
Szabó, Tamás
Capitanescu, Andrei
Stancu, Simona
Tisljar, Miroslav
Galesic, Kresimir
Tislér, András
Vainumäe, Inga
Windpessl, Martin
Zaoral, Tomas
Zlatanova, Galia
Csuka, Dorottya
author_sort Garam, Nóra
collection PubMed
description BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detailed analysis of functional complement markers. METHODS: A total of 92 patients with clinical, histological, complement and genetic data were involved in the study, and hierarchical cluster analysis was done by Ward method, where four clusters were generated. RESULTS: High levels of sC5b-9 (soluble membrane attack complex), low serum C3 levels and young age at onset (13 years) were characteristic for Cluster 1 with a high prevalence of likely pathogenic variations (LPVs) and C3 nephritic factor, whereas for Cluster 2—which is not reliable because of the small number of cases—strong immunoglobulin G staining, low C3 levels and high prevalence of nephritic syndrome at disease onset were observed. Low plasma sC5b-9 levels, decreased C3 levels and high prevalence of LPV and sclerotic glomeruli were present in Cluster 3, and patients with late onset of the disease (median: 39.5 years) and near-normal C3 levels in Cluster 4. A significant difference was observed in the incidence of end-stage renal disease during follow-up between the different clusters. Patients in Clusters 3–4 had worse renal survival than patients in Clusters 1–2. CONCLUSIONS: Our results confirm the main findings of the original cluster analysis and indicate that the observed, distinct pathogenic patterns are replicated in our cohort. Further investigations are necessary to analyse the distinct biological and pathogenic processes in these patient groups.
format Online
Article
Text
id pubmed-7147314
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71473142020-04-15 Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis Garam, Nóra Prohászka, Zoltán Szilágyi, Ágnes Aigner, Christof Schmidt, Alice Gaggl, Martina Sunder-Plassmann, Gere Bajcsi, Dóra Brunner, Jürgen Dumfarth, Alexandra Cejka, Daniel Flaschberger, Stefan Flögelova, Hana Haris, Ágnes Hartmann, Ágnes Heilos, Andreas Mueller, Thomas Rusai, Krisztina Arbeiter, Klaus Hofer, Johannes Jakab, Dániel Sinkó, Mária Szigeti, Erika Bereczki, Csaba Janko, Viktor Kelen, Kata Reusz, György S Szabó, Attila J Klenk, Nóra Kóbor, Krisztina Kojc, Nika Knechtelsdorfer, Maarten Laganovic, Mario Lungu, Adrian Catalin Meglic, Anamarija Rus, Rina Kersnik-Levart, Tanja Macioniene, Ernesta Miglinas, Marius Pawłowska, Anna Stompór, Tomasz Podracka, Ludmila Rudnicki, Michael Mayer, Gert Rysava, Romana Reiterova, Jana Saraga, Marijan Seeman, Tomáš Zieg, Jakub Sládková, Eva Szabó, Tamás Capitanescu, Andrei Stancu, Simona Tisljar, Miroslav Galesic, Kresimir Tislér, András Vainumäe, Inga Windpessl, Martin Zaoral, Tomas Zlatanova, Galia Csuka, Dorottya Clin Kidney J Original Articles BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detailed analysis of functional complement markers. METHODS: A total of 92 patients with clinical, histological, complement and genetic data were involved in the study, and hierarchical cluster analysis was done by Ward method, where four clusters were generated. RESULTS: High levels of sC5b-9 (soluble membrane attack complex), low serum C3 levels and young age at onset (13 years) were characteristic for Cluster 1 with a high prevalence of likely pathogenic variations (LPVs) and C3 nephritic factor, whereas for Cluster 2—which is not reliable because of the small number of cases—strong immunoglobulin G staining, low C3 levels and high prevalence of nephritic syndrome at disease onset were observed. Low plasma sC5b-9 levels, decreased C3 levels and high prevalence of LPV and sclerotic glomeruli were present in Cluster 3, and patients with late onset of the disease (median: 39.5 years) and near-normal C3 levels in Cluster 4. A significant difference was observed in the incidence of end-stage renal disease during follow-up between the different clusters. Patients in Clusters 3–4 had worse renal survival than patients in Clusters 1–2. CONCLUSIONS: Our results confirm the main findings of the original cluster analysis and indicate that the observed, distinct pathogenic patterns are replicated in our cohort. Further investigations are necessary to analyse the distinct biological and pathogenic processes in these patient groups. Oxford University Press 2019-06-21 /pmc/articles/PMC7147314/ /pubmed/32296528 http://dx.doi.org/10.1093/ckj/sfz073 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Garam, Nóra
Prohászka, Zoltán
Szilágyi, Ágnes
Aigner, Christof
Schmidt, Alice
Gaggl, Martina
Sunder-Plassmann, Gere
Bajcsi, Dóra
Brunner, Jürgen
Dumfarth, Alexandra
Cejka, Daniel
Flaschberger, Stefan
Flögelova, Hana
Haris, Ágnes
Hartmann, Ágnes
Heilos, Andreas
Mueller, Thomas
Rusai, Krisztina
Arbeiter, Klaus
Hofer, Johannes
Jakab, Dániel
Sinkó, Mária
Szigeti, Erika
Bereczki, Csaba
Janko, Viktor
Kelen, Kata
Reusz, György S
Szabó, Attila J
Klenk, Nóra
Kóbor, Krisztina
Kojc, Nika
Knechtelsdorfer, Maarten
Laganovic, Mario
Lungu, Adrian Catalin
Meglic, Anamarija
Rus, Rina
Kersnik-Levart, Tanja
Macioniene, Ernesta
Miglinas, Marius
Pawłowska, Anna
Stompór, Tomasz
Podracka, Ludmila
Rudnicki, Michael
Mayer, Gert
Rysava, Romana
Reiterova, Jana
Saraga, Marijan
Seeman, Tomáš
Zieg, Jakub
Sládková, Eva
Szabó, Tamás
Capitanescu, Andrei
Stancu, Simona
Tisljar, Miroslav
Galesic, Kresimir
Tislér, András
Vainumäe, Inga
Windpessl, Martin
Zaoral, Tomas
Zlatanova, Galia
Csuka, Dorottya
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title_full Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title_fullStr Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title_full_unstemmed Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title_short Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
title_sort validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147314/
https://www.ncbi.nlm.nih.gov/pubmed/32296528
http://dx.doi.org/10.1093/ckj/sfz073
work_keys_str_mv AT garamnora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT prohaszkazoltan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT szilagyiagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT aignerchristof validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT schmidtalice validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT gagglmartina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT sunderplassmanngere validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT bajcsidora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT brunnerjurgen validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT dumfarthalexandra validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT cejkadaniel validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT flaschbergerstefan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT flogelovahana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT harisagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT hartmannagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT heilosandreas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT muellerthomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT rusaikrisztina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT arbeiterklaus validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT hoferjohannes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT jakabdaniel validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT sinkomaria validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT szigetierika validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT bereczkicsaba validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT jankoviktor validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT kelenkata validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT reuszgyorgys validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT szaboattilaj validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT klenknora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT koborkrisztina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT kojcnika validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT knechtelsdorfermaarten validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT laganovicmario validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT lunguadriancatalin validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT meglicanamarija validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT rusrina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT kersniklevarttanja validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT macionieneernesta validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT miglinasmarius validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT pawłowskaanna validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT stomportomasz validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT podrackaludmila validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT rudnickimichael validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT mayergert validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT rysavaromana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT reiterovajana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT saragamarijan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT seemantomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT ziegjakub validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT sladkovaeva validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT szabotamas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT capitanescuandrei validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT stancusimona validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT tisljarmiroslav validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT galesickresimir validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT tislerandras validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT vainumaeinga validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT windpesslmartin validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT zaoraltomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT zlatanovagalia validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis
AT csukadorottya validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis